Paul Tudor Jones's TMDX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 40,217 shares of TransMedics Group, Inc. (TMDX) worth $4 M, representing 0.01% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in TMDX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 104,826 shares. Largest reduction occurred in Q3 2025, reducing 119,578 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's TransMedics Group (TMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly TransMedics Group (TMDX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +40,217 | New Buy | 40,217 | $99.41 |
| Q4 2025 | -4,138 | Sold Out | 0 | $0.00 |
| Q3 2025 | -119,578 | Reduce 96.66% | 4,138 | $112.20 |
| Q2 2025 | +18,890 | Add 18.02% | 123,716 | $134.01 |
| Q1 2025 | +104,826 | New Buy | 104,826 | $67.28 |
| Q3 2024 | -11,303 | Sold Out | 0 | $0.00 |
| Q2 2024 | +4,552 | Add 67.43% | 11,303 | $150.62 |
| Q1 2024 | -80,190 | Reduce 92.23% | 6,751 | $73.94 |
| Q4 2023 | +48,110 | Add 123.90% | 86,941 | $78.93 |
| Q3 2023 | +38,831 | New Buy | 38,831 | $54.75 |
| Q2 2023 | -40,582 | Sold Out | 0 | $0.00 |
| Q1 2023 | -35,628 | Reduce 46.75% | 40,582 | $0.08 |
| Q4 2022 | -6,796 | Reduce 8.19% | 76,210 | $0.06 |
| Q3 2022 | +74,584 | Add 885.59% | 83,006 | $41.74 |
| Q2 2022 | +8,422 | New Buy | 8,422 | $31.47 |
Paul Tudor Jones's TransMedics Group Investment FAQs
Paul Tudor Jones first purchased TransMedics Group, Inc. (TMDX) in Q2 2022, acquiring 8,422 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held TransMedics Group, Inc. (TMDX) for 15 quarters since Q2 2022.
Paul Tudor Jones's largest addition to TransMedics Group, Inc. (TMDX) was in Q1 2025, adding 104,826 shares worth $7.05 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 40,217 shares of TransMedics Group, Inc. (TMDX), valued at approximately $4 M.
As of the Q1 2026 filing, TransMedics Group, Inc. (TMDX) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in TransMedics Group, Inc. (TMDX) was 123,716 shares, as reported at the end of Q2 2025.